CRS - CYTOKINE RELEASE SYNDROME
Clinical trials for CRS - CYTOKINE RELEASE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CRS - CYTOKINE RELEASE SYNDROME trials appear
Sign up with your email to follow new studies for CRS - CYTOKINE RELEASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to tame dangerous immune reactions from cancer therapy
Disease control Recruiting nowThis early-phase study tests whether an investigational drug called Tadekinig alfa can safely and feasibly treat severe immune overreactions (CRS and HLH-like syndrome) that can occur after CAR T cell therapy. Ten adult participants who are already in a CAR T cell trial will rece…
Matched conditions: CRS - CYTOKINE RELEASE SYNDROME
Phase: EARLY_PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can smart monitoring predict dangerous side effects in blood cancer treatment?
Knowledge-focused Recruiting nowThis study aims to find early signs that a patient is developing serious complications, like cytokine release syndrome, after immunotherapy for blood cancer. Researchers will track vital signs and immune responses in 100 adults receiving CAR-T or bispecific antibody therapy. The …
Matched conditions: CRS - CYTOKINE RELEASE SYNDROME
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC